EU red blood cell research project to advance rare anaemia patient care

November 14, 2013
EU red blood cell research project to advance rare anaemia patient care
Credit: Shutterstock

Anaemia is a condition in which your blood has a lower than normal number of red blood cells. It affects 1.6 billion people worldwide, with approximately 10 percent of these individuals suffering from a rare form of the disease. Concretely, the lack of haemoglobin in the blood slows down the delivery of oxygen from the respiratory organs to the rest of the body, resulting in less energy to power the functions of the patient's organism. In such scenarios, various symptoms occur including fatigue, weakness and difficulty concentrating. If the anaemia becomes more severe - particularly in rare anaemias - it can become life threatening.

The root causes of the approximately 90 different types of red blood cell diseases have not yet been adequately investigated. The link between the molecular causes and clinical symptoms in red blood cell diseases like and groups of inherited - thalassemia - is still poorly understood and appropriate treatments are often ineffective.

As a consequence, there is a high demand for new tools to improve diagnosis and monitor red blood cell disease progression. This is where COMMITMENT - a newly launched EU funded research project - comes into play. Over the next five years, the project is expected to develop reliable imaging technologies for therapy and personalised medication in rare anaemia treatments.

The innovative approach of the international research group, led by Dr Lars Kaestner, Head of the Centre for Molecular Imaging and Screening at Saarland University, Germany, is based on the combination of specific imaging technologies (molecular and functional imaging).

"The individual technologies, and to a larger extent the unique fusion of technologies, will allow for the identification and probing of the molecular players that underlie rare anaemia. In doing so, this innovative technology will provide a novel diagnostic tool leading to a better understanding of the underlying pathophysiology of rare anaemia. This will enable us to develop new (personalised) treatments for this group of established, emerging, and as yet undiscovered red blood cell disorders," explains Dr Kaestner.

More information: www.rare-anaemia.eu/

Related Stories

Enzyme 'Lyn' linked to anaemia

August 21, 2013

New research by a team including experts from the UWA-affiliated Western Australian Institute for Medical Research (WAIMR) has proved a link between an enzyme known as "Lyn" and the blood disorder anaemia.

Recommended for you

A cheaper, high-performance prosthetic knee

July 30, 2015

In the last two decades, prosthetic limb technology has grown by leaps and bounds. Today, the most advanced prostheses incorporate microprocessors that work with onboard gyroscopes, accelerometers, and hydraulics to enable ...

Crystal clear images uncover secrets of hormone receptors

July 31, 2015

Many hormones and neurotransmitters work by binding to receptors on a cell's exterior surface. This activates receptors causing them to twist, turn and spark chemical reactions inside cells. NIH scientists used atomic level ...

Flow means 'go' for proper lymph system development

July 27, 2015

The lymphatic system provides a slow flow of fluid from our organs and tissues into the bloodstream. It returns fluid and proteins that leak from blood vessels, provides passage for immune and inflammatory cells from the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.